Yunjin Jeong

Yunjin Jeong

Auto-generated profile, based on publicly available information

Yunjin Jeong

Bio-MAX Institute, Seoul National University 1 , Seoul 08826, Republic of Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
SSSeo Woo Song
Seo Woo Song
SLSumin Lee
Sumin Lee
JCJun Kyu Choe
Jun Kyu Choe
NKNa-Hyang Kim
Na-Hyang Kim
JKJunwon Kang
Junwon Kang
JKJiyun Kim
Jiyun Kim
Technology for transforming a 2D pen drawing into a designed 3D structure enables highly accessible, rapid 3D fabrication.

11 January 2017 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
GSGustav Svedberg
Gustav Svedberg
YJYunjin Jeong
Yunjin Jeong
HNHunjong Na
Hunjong Na
JJJisung Jang
Jisung Jang
PNPeter Nilsson
Peter Nilsson
HSHelene Andersson Svahn
Helene Andersson Svahn
Highly multiplexed point of care tests could improve diagnostic accuracy and differential diagnostic capacity in for instance emergency medicine and low resource environments. Available technology platforms for POC biomarker detection are typically simplex or low-plexed, whereas common lab-based microarray systems allow for the simultaneous detection of thousands of DNA or protein biomarkers. In this study, we demonstrate a novel suspension particle array platform that utilizes 900 μm bricks for POC amenable colorimetric biomarker detection with an encoding capacity of over two million. Due to the mm-scale size, both the lithographic codes and colorimetric signals of individual particles can be visualized using a consumer grade office flatbed scanner, with a potential for simultaneous imaging of around 19 000 particles per scan. The analytical sensitivity of the assay was determined to be 4 ng ml−1 using an antibody model system. As a proof of concept, autoantibodies toward anoctamin 2 were detected in order to discriminate between multiple sclerosis plasma samples and healthy controls with p < 0.0001 and an inter-assay % CV of 9.44%.

19 August 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
YJYunjin Jeong
Yunjin Jeong
HJHAEWOOK JANG
HAEWOOK JANG
JKJunwon Kang
Junwon Kang
JNJuhong Nam
Juhong Nam
KSKyoungseob Shin
Kyoungseob Shin
JCJungil Choi
Jungil Choi
Since the discovery of antibiotics, the emergence of antibiotic resistance has become a global issue that is threatening society. In the era of antibiotic resistance, finding the proper antibiotics through antibiotic susceptibility testing (AST) is crucial in clinical settings. However, the current clinical process of AST based on the broth microdilution test has limitations on scalability to expand the number of antibiotics that are tested with various concentrations. Here, we used color-coded droplets to expand the multiplexing of AST regarding the kind and concentration of antibiotics. Color type and density differentiate the kind of antibiotics and concentration, respectively. Microscopic images of a large view field contain numbers of droplets with different testing conditions. Image processing analysis detects each droplet, decodes color codes, and measures the bacterial growth in the droplet. Testing E. coli ATCC 25922 with ampicillin, gentamicin, and tetracycline shows that the system can provide a robust and scalable platform for multiplexed AST. Furthermore, the system can be applied to various drug testing systems, which require several different testing conditions.

1 March 2024 in Biomicrofluidics
Verified
Journal Article
Closed access
PDF file
CPCheolheon Park
Cheolheon Park
YJYunjin Jeong
Yunjin Jeong
HYHuiran Yeom
Huiran Yeom
SSSeo Woo Song
Seo Woo Song
WPWook Park
Wook Park
Daewon LeeDaewon Lee
Daewon Lee
This study presents an innovative solution for the enhanced tracking and security of pharmaceuticals through the development of microstructures incorporating environmentally responsive, coded microparticles. Utilizing maskless photolithography, we engineered these microparticles with a degradable masking layer with 30 μm thickness that undergoes controlled dissolution. Quantitative analysis revealed that the protective layer's degradation, monitored by red fluorescence intensity, diminishes predictably over 144 h in phosphate-buffered saline under physiological conditions. This degradation not only confirms the microparticles' integrity but also allows the extraction of encoded information, which can serve as a robust indicator of medicinal shelf life and a deterrent to tampering. These findings indicate the potential for applying this technology in real-time monitoring of pharmaceuticals, ensuring quality and authenticity in the supply chain.